Summation Bio, Inc.
Biotechnology company · Somerville, Massachusetts, United States
Summation Bio, Inc. is a biotechnology company headquartered in Somerville, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $24 million sold in a notice filed in 2022.
Summation Bio at a glance
What does Summation Bio do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $24.5 million sold (2022).
Frequently asked questions about Summation Bio
Where is Summation Bio headquartered?
Summation Bio, Inc. is headquartered in Somerville, Massachusetts, United States.
What does Summation Bio do?
Summation Bio, Inc. is a biotechnology company.
When was Summation Bio founded?
The earliest incorporation on record for Summation Bio, Inc. is in 2018, according to public company registers.
Similar companies
- Biobot Analytics, Inc.Somerville, Massachusetts, United States
- Promakhos Therapeutics Inc.Somerville, Massachusetts, United States
- Metera Pharmaceuticals Inc.Somerville, Massachusetts, United States
- bluebird bio, Inc.Somerville, Massachusetts, United States
- DMK Pharmaceuticals CorporationSomerville, New Jersey, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences